JCO:未婚、分期较高的食管癌患者术后易患精神疾病

2015-02-11 Jessie 译 MedSci原创

Normal 0 10 pt 0 2 false false false EN-US ZH-CN X-NONE

心理困扰在癌症患者中普遍存在,其中抑郁的发生率较高,会增加患者的死亡风险。食管癌是预后较差的一种癌症(5年总生存率在10%以下),患者不仅遭受疾病带来的躯体痛苦,也遭受着严重的心理困扰。 

这项来自瑞典的研究,目的是调查食管癌患者术后精神疾病(如情感性精神障碍,神经质,物质依赖等)的累积发生率及危险因素,并探讨其对生存时间的影响。
 
该研究是一项全国性的基于人群的队列研究,1987年至2010年,共纳入了1615名接受了手术治疗的食管癌患者,并一直随访至2012年。关于精神疾病发生率的数据来自国家健康登记的信息,具体来说,是从患者的精神疾病治疗使用情况的数据推测而来。运用多元logistic回归分析来寻找患者术后出现精神疾病的潜在危险因素。运用多变量校正的Cox比例风险模型来分析总的生存率。
 
数据分析显示,没有精神疾病病史的患者,2年中因新发精神疾病住院治疗的累积发生率是2.5%,因精神疾病在门诊治疗的累积发生率为4.2%2年中累积有32.3%的患者使用精神病药物进行治疗。危险因素方面,已婚是一个保护因素:已婚的患者在食管癌术后患精神疾病的可能性较未婚者小,具体来说,已婚患者住院治疗的OR=0.4295% CI=0.220.80);门诊治疗的OR=0.4195% CI=0.171.02)。肿瘤分期较高是一个危险因素:分期越高越容易发生精神疾病,其中,肿瘤分期较高的患者接受门诊治疗的OR=4.9995% CI=1.1621.38),使用抗精神病药物治疗的OR=2.7895% CI=1.107.01)。考虑到可能的剩余混杂因素,新发精神疾病与患者的死亡率存在相关性,以风险比(hazard ratioHR)来衡量,住院治疗精神疾病的患者死亡的HR=1.6595% CI=1.172.33),门诊治疗的HR=1.9395% CI=1.183.16),药物治疗HR=2.7795% CI=1.724.44)。
 
食管癌患者术后发生精神疾病不仅影响患者的生活质量,而且影响患者的生存时间,临床工作者应当重视食管癌术后患者的精神疾病的筛查和治疗,其中,未婚及肿瘤分期较高的患者都是发生精神疾病的高危人群。
 
原始出处:

Anna Wikman, Rickard Ljung, Asif Johar, Ylva Hellstadius, Jesper Lagergren and Pernilla Lagergren.Psychiatric Morbidity and Survival After Surgery for Esophageal Cancer: A Population-Based Cohort Study. JCO 2015,33(5): 448-454.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1820931, encodeId=043e1820931ed, content=<a href='/topic/show?id=e89410109e51' target=_blank style='color:#2F92EE;'>#食管癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101097, encryptionId=e89410109e51, topicName=食管癌患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sun Apr 05 08:38:00 CST 2015, time=2015-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1891175, encodeId=c0de18911e502, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Wed Apr 01 20:38:00 CST 2015, time=2015-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23663, encodeId=ba4223663cb, content=才知道是这样, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:12:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16761, encodeId=04b316e617e, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Mon Feb 23 11:36:00 CST 2015, time=2015-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15730, encodeId=24a315e30bf, content=以阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 13:54:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15585, encodeId=0e171558517, content=是不是哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Mon Feb 16 08:16:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15453, encodeId=3a6215453b3, content=临床研究方案设计真的有很多学问, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=101.81.71.**, createdTime=Sun Feb 15 13:25:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1437095, encodeId=0e97143e0958e, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101059, encryptionId=0e311010591a, topicName=食管)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Feb 13 08:38:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15357, encodeId=0fe21535eca, content=从精神状态上做研究,可算是一种创新点了。考察患者的质量生存中,若加上精神这一点,从试验设计来讲加分大大的说!, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150602/IMG556D2C119C3EC8067.jpg, createdBy=e2ea89702, createdName=gongzuozhong, createdTime=Thu Feb 12 09:43:00 CST 2015, time=2015-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15348, encodeId=eee71534854, content=这也可以做研究!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=175.8.169.**, createdTime=Wed Feb 11 23:50:00 CST 2015, time=2015-02-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1820931, encodeId=043e1820931ed, content=<a href='/topic/show?id=e89410109e51' target=_blank style='color:#2F92EE;'>#食管癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101097, encryptionId=e89410109e51, topicName=食管癌患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sun Apr 05 08:38:00 CST 2015, time=2015-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1891175, encodeId=c0de18911e502, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Wed Apr 01 20:38:00 CST 2015, time=2015-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23663, encodeId=ba4223663cb, content=才知道是这样, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:12:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16761, encodeId=04b316e617e, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Mon Feb 23 11:36:00 CST 2015, time=2015-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15730, encodeId=24a315e30bf, content=以阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 13:54:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15585, encodeId=0e171558517, content=是不是哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Mon Feb 16 08:16:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15453, encodeId=3a6215453b3, content=临床研究方案设计真的有很多学问, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=101.81.71.**, createdTime=Sun Feb 15 13:25:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1437095, encodeId=0e97143e0958e, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101059, encryptionId=0e311010591a, topicName=食管)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Feb 13 08:38:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15357, encodeId=0fe21535eca, content=从精神状态上做研究,可算是一种创新点了。考察患者的质量生存中,若加上精神这一点,从试验设计来讲加分大大的说!, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150602/IMG556D2C119C3EC8067.jpg, createdBy=e2ea89702, createdName=gongzuozhong, createdTime=Thu Feb 12 09:43:00 CST 2015, time=2015-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15348, encodeId=eee71534854, content=这也可以做研究!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=175.8.169.**, createdTime=Wed Feb 11 23:50:00 CST 2015, time=2015-02-11, status=1, ipAttribution=)]
    2015-04-01 lidong40
  3. [GetPortalCommentsPageByObjectIdResponse(id=1820931, encodeId=043e1820931ed, content=<a href='/topic/show?id=e89410109e51' target=_blank style='color:#2F92EE;'>#食管癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101097, encryptionId=e89410109e51, topicName=食管癌患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sun Apr 05 08:38:00 CST 2015, time=2015-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1891175, encodeId=c0de18911e502, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Wed Apr 01 20:38:00 CST 2015, time=2015-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23663, encodeId=ba4223663cb, content=才知道是这样, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:12:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16761, encodeId=04b316e617e, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Mon Feb 23 11:36:00 CST 2015, time=2015-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15730, encodeId=24a315e30bf, content=以阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 13:54:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15585, encodeId=0e171558517, content=是不是哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Mon Feb 16 08:16:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15453, encodeId=3a6215453b3, content=临床研究方案设计真的有很多学问, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=101.81.71.**, createdTime=Sun Feb 15 13:25:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1437095, encodeId=0e97143e0958e, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101059, encryptionId=0e311010591a, topicName=食管)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Feb 13 08:38:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15357, encodeId=0fe21535eca, content=从精神状态上做研究,可算是一种创新点了。考察患者的质量生存中,若加上精神这一点,从试验设计来讲加分大大的说!, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150602/IMG556D2C119C3EC8067.jpg, createdBy=e2ea89702, createdName=gongzuozhong, createdTime=Thu Feb 12 09:43:00 CST 2015, time=2015-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15348, encodeId=eee71534854, content=这也可以做研究!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=175.8.169.**, createdTime=Wed Feb 11 23:50:00 CST 2015, time=2015-02-11, status=1, ipAttribution=)]
    2015-05-16 ljjj1053

    才知道是这样

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1820931, encodeId=043e1820931ed, content=<a href='/topic/show?id=e89410109e51' target=_blank style='color:#2F92EE;'>#食管癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101097, encryptionId=e89410109e51, topicName=食管癌患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sun Apr 05 08:38:00 CST 2015, time=2015-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1891175, encodeId=c0de18911e502, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Wed Apr 01 20:38:00 CST 2015, time=2015-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23663, encodeId=ba4223663cb, content=才知道是这样, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:12:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16761, encodeId=04b316e617e, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Mon Feb 23 11:36:00 CST 2015, time=2015-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15730, encodeId=24a315e30bf, content=以阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 13:54:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15585, encodeId=0e171558517, content=是不是哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Mon Feb 16 08:16:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15453, encodeId=3a6215453b3, content=临床研究方案设计真的有很多学问, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=101.81.71.**, createdTime=Sun Feb 15 13:25:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1437095, encodeId=0e97143e0958e, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101059, encryptionId=0e311010591a, topicName=食管)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Feb 13 08:38:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15357, encodeId=0fe21535eca, content=从精神状态上做研究,可算是一种创新点了。考察患者的质量生存中,若加上精神这一点,从试验设计来讲加分大大的说!, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150602/IMG556D2C119C3EC8067.jpg, createdBy=e2ea89702, createdName=gongzuozhong, createdTime=Thu Feb 12 09:43:00 CST 2015, time=2015-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15348, encodeId=eee71534854, content=这也可以做研究!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=175.8.169.**, createdTime=Wed Feb 11 23:50:00 CST 2015, time=2015-02-11, status=1, ipAttribution=)]
    2015-02-23 orthoW

    不错的文章,学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1820931, encodeId=043e1820931ed, content=<a href='/topic/show?id=e89410109e51' target=_blank style='color:#2F92EE;'>#食管癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101097, encryptionId=e89410109e51, topicName=食管癌患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sun Apr 05 08:38:00 CST 2015, time=2015-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1891175, encodeId=c0de18911e502, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Wed Apr 01 20:38:00 CST 2015, time=2015-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23663, encodeId=ba4223663cb, content=才知道是这样, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:12:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16761, encodeId=04b316e617e, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Mon Feb 23 11:36:00 CST 2015, time=2015-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15730, encodeId=24a315e30bf, content=以阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 13:54:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15585, encodeId=0e171558517, content=是不是哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Mon Feb 16 08:16:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15453, encodeId=3a6215453b3, content=临床研究方案设计真的有很多学问, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=101.81.71.**, createdTime=Sun Feb 15 13:25:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1437095, encodeId=0e97143e0958e, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101059, encryptionId=0e311010591a, topicName=食管)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Feb 13 08:38:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15357, encodeId=0fe21535eca, content=从精神状态上做研究,可算是一种创新点了。考察患者的质量生存中,若加上精神这一点,从试验设计来讲加分大大的说!, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150602/IMG556D2C119C3EC8067.jpg, createdBy=e2ea89702, createdName=gongzuozhong, createdTime=Thu Feb 12 09:43:00 CST 2015, time=2015-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15348, encodeId=eee71534854, content=这也可以做研究!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=175.8.169.**, createdTime=Wed Feb 11 23:50:00 CST 2015, time=2015-02-11, status=1, ipAttribution=)]
    2015-02-16 windmilL1989

    以阅

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1820931, encodeId=043e1820931ed, content=<a href='/topic/show?id=e89410109e51' target=_blank style='color:#2F92EE;'>#食管癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101097, encryptionId=e89410109e51, topicName=食管癌患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sun Apr 05 08:38:00 CST 2015, time=2015-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1891175, encodeId=c0de18911e502, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Wed Apr 01 20:38:00 CST 2015, time=2015-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23663, encodeId=ba4223663cb, content=才知道是这样, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:12:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16761, encodeId=04b316e617e, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Mon Feb 23 11:36:00 CST 2015, time=2015-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15730, encodeId=24a315e30bf, content=以阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 13:54:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15585, encodeId=0e171558517, content=是不是哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Mon Feb 16 08:16:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15453, encodeId=3a6215453b3, content=临床研究方案设计真的有很多学问, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=101.81.71.**, createdTime=Sun Feb 15 13:25:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1437095, encodeId=0e97143e0958e, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101059, encryptionId=0e311010591a, topicName=食管)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Feb 13 08:38:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15357, encodeId=0fe21535eca, content=从精神状态上做研究,可算是一种创新点了。考察患者的质量生存中,若加上精神这一点,从试验设计来讲加分大大的说!, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150602/IMG556D2C119C3EC8067.jpg, createdBy=e2ea89702, createdName=gongzuozhong, createdTime=Thu Feb 12 09:43:00 CST 2015, time=2015-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15348, encodeId=eee71534854, content=这也可以做研究!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=175.8.169.**, createdTime=Wed Feb 11 23:50:00 CST 2015, time=2015-02-11, status=1, ipAttribution=)]
    2015-02-16 jianlion

    是不是哦

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1820931, encodeId=043e1820931ed, content=<a href='/topic/show?id=e89410109e51' target=_blank style='color:#2F92EE;'>#食管癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101097, encryptionId=e89410109e51, topicName=食管癌患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sun Apr 05 08:38:00 CST 2015, time=2015-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1891175, encodeId=c0de18911e502, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Wed Apr 01 20:38:00 CST 2015, time=2015-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23663, encodeId=ba4223663cb, content=才知道是这样, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:12:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16761, encodeId=04b316e617e, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Mon Feb 23 11:36:00 CST 2015, time=2015-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15730, encodeId=24a315e30bf, content=以阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 13:54:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15585, encodeId=0e171558517, content=是不是哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Mon Feb 16 08:16:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15453, encodeId=3a6215453b3, content=临床研究方案设计真的有很多学问, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=101.81.71.**, createdTime=Sun Feb 15 13:25:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1437095, encodeId=0e97143e0958e, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101059, encryptionId=0e311010591a, topicName=食管)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Feb 13 08:38:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15357, encodeId=0fe21535eca, content=从精神状态上做研究,可算是一种创新点了。考察患者的质量生存中,若加上精神这一点,从试验设计来讲加分大大的说!, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150602/IMG556D2C119C3EC8067.jpg, createdBy=e2ea89702, createdName=gongzuozhong, createdTime=Thu Feb 12 09:43:00 CST 2015, time=2015-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15348, encodeId=eee71534854, content=这也可以做研究!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=175.8.169.**, createdTime=Wed Feb 11 23:50:00 CST 2015, time=2015-02-11, status=1, ipAttribution=)]
    2015-02-15 101.81.71.**

    临床研究方案设计真的有很多学问

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1820931, encodeId=043e1820931ed, content=<a href='/topic/show?id=e89410109e51' target=_blank style='color:#2F92EE;'>#食管癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101097, encryptionId=e89410109e51, topicName=食管癌患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sun Apr 05 08:38:00 CST 2015, time=2015-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1891175, encodeId=c0de18911e502, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Wed Apr 01 20:38:00 CST 2015, time=2015-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23663, encodeId=ba4223663cb, content=才知道是这样, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:12:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16761, encodeId=04b316e617e, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Mon Feb 23 11:36:00 CST 2015, time=2015-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15730, encodeId=24a315e30bf, content=以阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 13:54:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15585, encodeId=0e171558517, content=是不是哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Mon Feb 16 08:16:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15453, encodeId=3a6215453b3, content=临床研究方案设计真的有很多学问, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=101.81.71.**, createdTime=Sun Feb 15 13:25:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1437095, encodeId=0e97143e0958e, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101059, encryptionId=0e311010591a, topicName=食管)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Feb 13 08:38:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15357, encodeId=0fe21535eca, content=从精神状态上做研究,可算是一种创新点了。考察患者的质量生存中,若加上精神这一点,从试验设计来讲加分大大的说!, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150602/IMG556D2C119C3EC8067.jpg, createdBy=e2ea89702, createdName=gongzuozhong, createdTime=Thu Feb 12 09:43:00 CST 2015, time=2015-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15348, encodeId=eee71534854, content=这也可以做研究!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=175.8.169.**, createdTime=Wed Feb 11 23:50:00 CST 2015, time=2015-02-11, status=1, ipAttribution=)]
    2015-02-13 zhouqu_8
  9. [GetPortalCommentsPageByObjectIdResponse(id=1820931, encodeId=043e1820931ed, content=<a href='/topic/show?id=e89410109e51' target=_blank style='color:#2F92EE;'>#食管癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101097, encryptionId=e89410109e51, topicName=食管癌患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sun Apr 05 08:38:00 CST 2015, time=2015-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1891175, encodeId=c0de18911e502, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Wed Apr 01 20:38:00 CST 2015, time=2015-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23663, encodeId=ba4223663cb, content=才知道是这样, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:12:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16761, encodeId=04b316e617e, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Mon Feb 23 11:36:00 CST 2015, time=2015-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15730, encodeId=24a315e30bf, content=以阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 13:54:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15585, encodeId=0e171558517, content=是不是哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Mon Feb 16 08:16:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15453, encodeId=3a6215453b3, content=临床研究方案设计真的有很多学问, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=101.81.71.**, createdTime=Sun Feb 15 13:25:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1437095, encodeId=0e97143e0958e, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101059, encryptionId=0e311010591a, topicName=食管)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Feb 13 08:38:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15357, encodeId=0fe21535eca, content=从精神状态上做研究,可算是一种创新点了。考察患者的质量生存中,若加上精神这一点,从试验设计来讲加分大大的说!, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150602/IMG556D2C119C3EC8067.jpg, createdBy=e2ea89702, createdName=gongzuozhong, createdTime=Thu Feb 12 09:43:00 CST 2015, time=2015-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15348, encodeId=eee71534854, content=这也可以做研究!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=175.8.169.**, createdTime=Wed Feb 11 23:50:00 CST 2015, time=2015-02-11, status=1, ipAttribution=)]
    2015-02-12 gongzuozhong

    从精神状态上做研究,可算是一种创新点了。考察患者的质量生存中,若加上精神这一点,从试验设计来讲加分大大的说!

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1820931, encodeId=043e1820931ed, content=<a href='/topic/show?id=e89410109e51' target=_blank style='color:#2F92EE;'>#食管癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101097, encryptionId=e89410109e51, topicName=食管癌患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sun Apr 05 08:38:00 CST 2015, time=2015-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1891175, encodeId=c0de18911e502, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Wed Apr 01 20:38:00 CST 2015, time=2015-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23663, encodeId=ba4223663cb, content=才知道是这样, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:12:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16761, encodeId=04b316e617e, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Mon Feb 23 11:36:00 CST 2015, time=2015-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15730, encodeId=24a315e30bf, content=以阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 13:54:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15585, encodeId=0e171558517, content=是不是哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Mon Feb 16 08:16:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15453, encodeId=3a6215453b3, content=临床研究方案设计真的有很多学问, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=101.81.71.**, createdTime=Sun Feb 15 13:25:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1437095, encodeId=0e97143e0958e, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101059, encryptionId=0e311010591a, topicName=食管)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Feb 13 08:38:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15357, encodeId=0fe21535eca, content=从精神状态上做研究,可算是一种创新点了。考察患者的质量生存中,若加上精神这一点,从试验设计来讲加分大大的说!, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150602/IMG556D2C119C3EC8067.jpg, createdBy=e2ea89702, createdName=gongzuozhong, createdTime=Thu Feb 12 09:43:00 CST 2015, time=2015-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15348, encodeId=eee71534854, content=这也可以做研究!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=175.8.169.**, createdTime=Wed Feb 11 23:50:00 CST 2015, time=2015-02-11, status=1, ipAttribution=)]
    2015-02-11 175.8.169.**

    这也可以做研究!

    0

相关资讯

NEJM:食管腺癌临床诊疗综述

在北美和欧洲食管腺癌是最主要的食管癌类型。胃食管返流性疾病(GERD)和肥胖是主要危险因素。目前已经知道的癌前损害是Barrett食管,通过内镜检查发现,发现后按照癌前损害进行治疗和监控。亚洲、非洲、南美和北美的黑人食管鳞癌是食管癌主要类型。酒精和烟草是主要危险因素,食管鳞状异型增生是主要癌前损害。过去的10年里,尽管食管癌5年生存率仍然很差,但已有改善,早期和局部进展期食管癌病人长期生存可能

全新UICC食管癌TNM分期

最新国际食管癌TNM分期(UICC/AJCC 2009第7版) 一、食管癌的分段 与以往不同,新版食管癌TNM标准对食管癌的原发部位以肿块上缘所在的食管位置决定,以上切牙到肿块上缘的距离来表示具体位置: 颈段食管:上接下咽,向下至胸骨切迹平面的胸廓入口,内镜检查距门齿15厘米至<20厘米。 胸上段食管:上自胸廓入口,下至奇静脉弓下缘水平,内镜检查距门齿20厘米至<25厘米。

Int J Radiat Oncol Biol Phys:术前放化疗结合帕尼单抗治疗可切除食管癌:2期临床试验

目的:术前放化疗治疗(CRT)已成为可切除食管癌患者的标准治疗策略。该多中心2期临床研究旨在研究添加表皮生长因子受体(EGFR)抑制剂—帕尼单抗对于接受术前放化疗治疗(卡铂、紫杉醇和放射治疗)的可切除食管癌患者的功效。方法:具有可切除 cT1N1M0 或者 cT2-3N0 到 -2M0 肿瘤的患者在第1、15和29天接受含帕尼单抗(6 mg/kg)的术前放化疗治疗,每周给药卡铂(曲线下面积[AUC

ASCO GI 2015 :MIRO研究:可切除食管癌行混合微创食管切除术有短期获益

MIRO研究:食管癌患者混合微创和开放性食管切除术比较(摘要号:5) 报告者:Christophe Mariette 报告时间:旧金山时间1月15日,2:00 pm~3:30 pm 研究背景:外科手术被认为是可切除食管癌的唯一治疗选择。术后并发症,特别是肺部并发症,仍然是引起诸多关注的焦点,一半以上行开放性食管切除术(OO)的患者出现并发症。本研究对混合微创食管切除术(HMIO)与OO进行比

ASCO GI 2015 :TROG 03.01研究:进展期食管癌的姑息性化放疗VS放疗

TROG 03.01研究:进展期食管癌患者放疗或化放疗后吞咽困难缓解和生活质量比较(摘要号:6) 报告者:Michael Penniment 报告时间:旧金山时间1月15日,2:00 pm~3:30 pm 研究背景 放射治疗(RT)可缓解进展期食管癌患者的吞咽困难症状,但尚无Ⅲ期随机试验数据确定其治疗反应、毒性以及姑息性化放疗(CRT)的作用。本研究旨在确立有效、最小毒性的治疗方式以缓解症

吉非替尼靶向疗法或可提高食管癌患者的生存期

近日,在国家癌症研究所癌症(NCRI)会议上,来自阿伯丁大学的研究人员通过研究表示,一种用于治疗肺癌的最新药物可使得特殊食管癌的病人生存期明显延长。在高达六分之一的食管癌患者机体的肿瘤细胞中都能够发现EGFR的复制品,而患者往往通过服用药物吉非替尼来靶向作用该“错误”,进而可以将患者寿命延长至6个月,有时候甚至更长。 抗肿瘤药吉非替尼是一种表皮生长因子受体抑制剂,其已经在日本、美国和澳大利亚